E
Apyx Medical Corporation
APYX
$0.9934
-$0.1666-14.36%
E
Sell
4/2/2025Downgrade
Apyx Medical Corporation (APYX) was downgraded to E+ from D- on 4/2/2025 due to a decline in the valuation index and total return index.
Apyx Medical Corporation (APYX) was downgraded to E+ from D- on 4/2/2025 due to a decline in the valuation index and total return index.
D
Sell
3/17/2025Upgraded
Apyx Medical Corporation (APYX) was upgraded to D- from E+ on 3/17/2025 due to an increase in the total return index, volatility index and valuation index.
Apyx Medical Corporation (APYX) was upgraded to D- from E+ on 3/17/2025 due to an increase in the total return index, volatility index and valuation index.
E
Sell
6/14/2024Downgrade
Apyx Medical Corporation (APYX) was downgraded to E+ from D- on 6/14/2024 due to a decline in the volatility index and total return index.
Apyx Medical Corporation (APYX) was downgraded to E+ from D- on 6/14/2024 due to a decline in the volatility index and total return index.
D
Sell
5/28/2024Upgraded
Apyx Medical Corporation (APYX) was upgraded to D- from E+ on 5/28/2024 due to an increase in the growth index, valuation index and volatility index. Earnings per share increased from -$0.2773 to -$0.2187.
Apyx Medical Corporation (APYX) was upgraded to D- from E+ on 5/28/2024 due to an increase in the growth index, valuation index and volatility index. Earnings per share increased from -$0.2773 to -$0.2187.
E
Sell
2/16/2024Downgrade
Apyx Medical Corporation (APYX) was downgraded to E+ from D- on 2/16/2024 due to a decline in the volatility index and valuation index.
Apyx Medical Corporation (APYX) was downgraded to E+ from D- on 2/16/2024 due to a decline in the volatility index and valuation index.
D
Sell
2/1/2024Upgraded
Apyx Medical Corporation (APYX) was upgraded to D- from E+ on 2/1/2024 due to an increase in the valuation index.
Apyx Medical Corporation (APYX) was upgraded to D- from E+ on 2/1/2024 due to an increase in the valuation index.
E
Sell
1/9/2024Downgrade
Apyx Medical Corporation (APYX) was downgraded to E+ from D- on 1/9/2024 due to a substantial decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.0287 to -$0.1336, EBIT declined 26.11% from -$3.68M to -$4.64M, and total revenue declined 11.74% from $13.57M to $11.98M.
Apyx Medical Corporation (APYX) was downgraded to E+ from D- on 1/9/2024 due to a substantial decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.0287 to -$0.1336, EBIT declined 26.11% from -$3.68M to -$4.64M, and total revenue declined 11.74% from $13.57M to $11.98M.
D
Sell
8/14/2023Upgraded
Apyx Medical Corporation (APYX) was upgraded to D- from E+ on 8/14/2023 due to a substantial increase in the growth index, total return index and solvency index. Earnings per share increased from -$0.1007 to -$0.0287, EBIT increased 34.47% from -$5.61M to -$3.68M, and total revenue increased 11.75% from $12.14M to $13.57M.
Apyx Medical Corporation (APYX) was upgraded to D- from E+ on 8/14/2023 due to a substantial increase in the growth index, total return index and solvency index. Earnings per share increased from -$0.1007 to -$0.0287, EBIT increased 34.47% from -$5.61M to -$3.68M, and total revenue increased 11.75% from $12.14M to $13.57M.
E
Sell
5/22/2023Downgrade
Apyx Medical Corporation (APYX) was downgraded to E+ from D- on 5/22/2023 due to a noticeable decline in the solvency index, growth index and valuation index. The quick ratio declined from 2.81 to 2.41, earnings per share declined from -$0.1667 to -$0.1748, and EBIT declined 2.61% from -$5.78M to -$5.93M.
Apyx Medical Corporation (APYX) was downgraded to E+ from D- on 5/22/2023 due to a noticeable decline in the solvency index, growth index and valuation index. The quick ratio declined from 2.81 to 2.41, earnings per share declined from -$0.1667 to -$0.1748, and EBIT declined 2.61% from -$5.78M to -$5.93M.
D
Sell
3/14/2023Downgrade
Apyx Medical Corporation (APYX) was downgraded to D- from D on 03/14/2023.
Apyx Medical Corporation (APYX) was downgraded to D- from D on 03/14/2023.
D
Sell
2/23/2023Upgraded
Apyx Medical Corporation (APYX) was upgraded to D from D- on 02/23/2023.
Apyx Medical Corporation (APYX) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
Apyx Medical Corporation (APYX) was downgraded to D- from D on 2/8/2023 due to a major decline in the total return index and solvency index. The quick ratio declined from 3.35 to 2.81.
Apyx Medical Corporation (APYX) was downgraded to D- from D on 2/8/2023 due to a major decline in the total return index and solvency index. The quick ratio declined from 3.35 to 2.81.
D
Sell
5/16/2022Upgraded
Apyx Medical Corporation (APYX) was upgraded to D from D- on 5/16/2022 due to an increase in the valuation index.
Apyx Medical Corporation (APYX) was upgraded to D from D- on 5/16/2022 due to an increase in the valuation index.
D
Sell
5/1/2022Downgrade
Apyx Medical Corporation (APYX) was downgraded to D- from D+ on 5/1/2022 due to a decline in the volatility index.
Apyx Medical Corporation (APYX) was downgraded to D- from D+ on 5/1/2022 due to a decline in the volatility index.
D
Sell
4/21/2022Upgraded
Apyx Medical Corporation (APYX) was upgraded to D+ from D- on 4/21/2022 due to an increase in the valuation index.
Apyx Medical Corporation (APYX) was upgraded to D+ from D- on 4/21/2022 due to an increase in the valuation index.
D
Sell
4/20/2022Downgrade
Apyx Medical Corporation (APYX) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index, growth index and volatility index.
Apyx Medical Corporation (APYX) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index, growth index and volatility index.
D
Sell
11/15/2021Upgraded
Apyx Medical Corporation (APYX) was upgraded to D from D- on 11/15/2021 due to an increase in the total return index.
Apyx Medical Corporation (APYX) was upgraded to D from D- on 11/15/2021 due to an increase in the total return index.
D
Sell
11/8/2021Downgrade
Apyx Medical Corporation (APYX) was downgraded to D- from D on 11/8/2021 due to a significant decline in the efficiency index and valuation index. Total capital declined 4.21% from $60.73M to $58.17M.
Apyx Medical Corporation (APYX) was downgraded to D- from D on 11/8/2021 due to a significant decline in the efficiency index and valuation index. Total capital declined 4.21% from $60.73M to $58.17M.
D
Sell
9/21/2020Downgrade
Apyx Medical Corporation (APYX) was downgraded to D from D+ on 9/21/2020 due to a decline in the total return index.
Apyx Medical Corporation (APYX) was downgraded to D from D+ on 9/21/2020 due to a decline in the total return index.
D
Sell
8/12/2020Upgraded
Apyx Medical Corporation (APYX) was upgraded to D+ from D on 8/12/2020 due to an increase in the efficiency index, total return index and solvency index. The quick ratio increased from 6.02 to 6.29.
Apyx Medical Corporation (APYX) was upgraded to D+ from D on 8/12/2020 due to an increase in the efficiency index, total return index and solvency index. The quick ratio increased from 6.02 to 6.29.
D
Sell
4/6/2020Downgrade
Apyx Medical Corporation (APYX) was downgraded to D from D+ on 4/6/2020 due to a substantial decline in the total return index, efficiency index and solvency index. Net income declined 34.68% from -$4.31M to -$5.81M, the quick ratio declined from 7.74 to 5.53, and total capital declined 7.03% from $77.86M to $72.39M.
Apyx Medical Corporation (APYX) was downgraded to D from D+ on 4/6/2020 due to a substantial decline in the total return index, efficiency index and solvency index. Net income declined 34.68% from -$4.31M to -$5.81M, the quick ratio declined from 7.74 to 5.53, and total capital declined 7.03% from $77.86M to $72.39M.
D
Sell
11/21/2019Downgrade
Apyx Medical Corporation (APYX) was downgraded to D+ from C- on 11/21/2019 due to a noticeable decline in the total return index.
Apyx Medical Corporation (APYX) was downgraded to D+ from C- on 11/21/2019 due to a noticeable decline in the total return index.
C
Hold
11/15/2019Downgrade
Apyx Medical Corporation (APYX) was downgraded to C- from C+ on 11/15/2019 due to a significant decline in the valuation index, efficiency index and growth index. EBIT declined 5.2% from -$4.47M to -$4.7M, and total capital declined 3.86% from $80.99M to $77.86M.
Apyx Medical Corporation (APYX) was downgraded to C- from C+ on 11/15/2019 due to a significant decline in the valuation index, efficiency index and growth index. EBIT declined 5.2% from -$4.47M to -$4.7M, and total capital declined 3.86% from $80.99M to $77.86M.
C
Hold
8/8/2019Upgraded
Apyx Medical Corporation (APYX) was upgraded to C+ from C on 8/8/2019 due to a noticeable increase in the growth index and efficiency index. EBIT increased 14.18% from -$5.2M to -$4.47M, total revenue increased 12.79% from $5.82M to $6.57M, and earnings per share increased from -$0.1404 to -$0.13.
Apyx Medical Corporation (APYX) was upgraded to C+ from C on 8/8/2019 due to a noticeable increase in the growth index and efficiency index. EBIT increased 14.18% from -$5.2M to -$4.47M, total revenue increased 12.79% from $5.82M to $6.57M, and earnings per share increased from -$0.1404 to -$0.13.
C
Hold
3/29/2019Downgrade
Apyx Medical Corporation (APYX) was downgraded to C from C+ on 3/29/2019 due to a major decline in the growth index, solvency index and valuation index. Earnings per share declined from $2.0789 to -$0.1175, and EBIT declined 57.73% from -$2.8M to -$4.41M.
Apyx Medical Corporation (APYX) was downgraded to C from C+ on 3/29/2019 due to a major decline in the growth index, solvency index and valuation index. Earnings per share declined from $2.0789 to -$0.1175, and EBIT declined 57.73% from -$2.8M to -$4.41M.
C
Hold
11/8/2018Upgraded
Bovie Medical Corporation (BVX) was upgraded to C+ from C- on 11/8/2018 due to a significant increase in the valuation index, efficiency index and growth index. Net income increased 25,531.62% from -$272 to $69.17M, earnings per share increased from -$0.0172 to $2.0789, and total capital increased 276.49% from $24.29M to $91.44M.
Bovie Medical Corporation (BVX) was upgraded to C+ from C- on 11/8/2018 due to a significant increase in the valuation index, efficiency index and growth index. Net income increased 25,531.62% from -$272 to $69.17M, earnings per share increased from -$0.0172 to $2.0789, and total capital increased 276.49% from $24.29M to $91.44M.
C
Hold
7/16/2018Upgraded
Bovie Medical Corporation (BVX) was upgraded to C- from D+ on 7/16/2018 due to a substantial increase in the total return index.
Bovie Medical Corporation (BVX) was upgraded to C- from D+ on 7/16/2018 due to a substantial increase in the total return index.
D
Sell
6/7/2018Upgraded
Bovie Medical Corporation (BVX) was upgraded to D+ from D on 6/7/2018 due to an increase in the total return index.
Bovie Medical Corporation (BVX) was upgraded to D+ from D on 6/7/2018 due to an increase in the total return index.
D
Sell
5/23/2018Downgrade
Bovie Medical Corporation (BVX) was downgraded to D from D+ on 5/23/2018 due to a large decline in the growth index, valuation index and solvency index. EBIT declined 298.17% from $436 to -$864, operating cash flow declined 251.57% from $731 to -$1.11M, and total revenue declined 12.62% from $11.35M to $9.92M.
Bovie Medical Corporation (BVX) was downgraded to D from D+ on 5/23/2018 due to a large decline in the growth index, valuation index and solvency index. EBIT declined 298.17% from $436 to -$864, operating cash flow declined 251.57% from $731 to -$1.11M, and total revenue declined 12.62% from $11.35M to $9.92M.
D
Sell
5/8/2018Upgraded
Bovie Medical Corporation (BVX) was upgraded to D+ from D on 5/8/2018 due to an increase in the solvency index, total return index and efficiency index. Net income increased 33.82% from -$1.25M to -$824.
Bovie Medical Corporation (BVX) was upgraded to D+ from D on 5/8/2018 due to an increase in the solvency index, total return index and efficiency index. Net income increased 33.82% from -$1.25M to -$824.
D
Sell
11/1/2017Downgrade
Bovie Medical Corporation (BVX) was downgraded to D from D+ on 11/1/2017 due to a decline in the valuation index.
Bovie Medical Corporation (BVX) was downgraded to D from D+ on 11/1/2017 due to a decline in the valuation index.
D
Sell
10/10/2017Upgraded
Bovie Medical Corporation (BVX) was upgraded to D+ from D on 10/10/2017 due to a large increase in the total return index, volatility index and efficiency index. Net income increased 22.37% from -$1.69M to -$1.31M.
Bovie Medical Corporation (BVX) was upgraded to D+ from D on 10/10/2017 due to a large increase in the total return index, volatility index and efficiency index. Net income increased 22.37% from -$1.69M to -$1.31M.
D
Sell
3/18/2016Upgraded
Bovie Medical Corporation (BVX) was upgraded to D from D- on 3/18/2016 due to a major increase in the valuation index, growth index and efficiency index. EBIT increased 25.48% from -$1.81M to -$1.35M, earnings per share increased from -$0.06 to -$0.052, and net income increased 11.34% from -$1.59M to -$1.41M.
Bovie Medical Corporation (BVX) was upgraded to D from D- on 3/18/2016 due to a major increase in the valuation index, growth index and efficiency index. EBIT increased 25.48% from -$1.81M to -$1.35M, earnings per share increased from -$0.06 to -$0.052, and net income increased 11.34% from -$1.59M to -$1.41M.
D
Sell
3/11/2016Downgrade
Bovie Medical Corporation (BVX) was downgraded to D- from D+ on 3/11/2016 due to a major decline in the volatility index, total return index and solvency index.
Bovie Medical Corporation (BVX) was downgraded to D- from D+ on 3/11/2016 due to a major decline in the volatility index, total return index and solvency index.
D
Sell
11/13/2015Upgraded
Bovie Medical Corporation (BVX) was upgraded to D+ from D on 11/13/2015 due to a significant increase in the valuation index, solvency index and growth index. EBIT increased 17.12% from -$1.55M to -$1.81M, and total revenue increased 7.55% from $7.27M to $7.82M.
Bovie Medical Corporation (BVX) was upgraded to D+ from D on 11/13/2015 due to a significant increase in the valuation index, solvency index and growth index. EBIT increased 17.12% from -$1.55M to -$1.81M, and total revenue increased 7.55% from $7.27M to $7.82M.
D
Sell
5/23/2014Downgrade
Bovie Medical Corp. (BVX) was downgraded to D from C- on 5/23/2014 due to a major decline in the efficiency index, solvency index and valuation index. Debt to equity increased from 0.17 to 0.38, and total capital declined 37.38% from $24.59M to $15.4M.
Bovie Medical Corp. (BVX) was downgraded to D from C- on 5/23/2014 due to a major decline in the efficiency index, solvency index and valuation index. Debt to equity increased from 0.17 to 0.38, and total capital declined 37.38% from $24.59M to $15.4M.
C
Hold
3/26/2014Upgraded
Bovie Medical Corp. (BVX) was upgraded to C- from D+ on 3/26/2014 due to an increase in the volatility index, total return index and efficiency index.
Bovie Medical Corp. (BVX) was upgraded to C- from D+ on 3/26/2014 due to an increase in the volatility index, total return index and efficiency index.
NASDAQ
04/04/2025 12:22PM Eastern
Quotes delayed
